A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

January 27, 2026

Study Completion Date

January 27, 2026

Conditions

Advanced Solid TumorsHCC

Interventions

DRUG

IMM27M

Intravenous injection

DRUG

IMM2510

Intravenous injection

Trial Locations (1)

RECRUITING

ZhongShan Hospital Fudan University, Shanghai

All Listed Sponsors

lead

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

OTHER